Yi He
12Patents
1h-index
32Co-inventors
54Inventor score
Filing activity: Dec 10, 1999 → Jan 28, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6379709B1 | Angiogenesis inhibitors and activators from shark cartilage | Human Necessities | 2 | Expired |
| US10376491B2 | Pharmaceutical composition containing silibinin and pueraria root extract | Emerging Cross-Sectional Technologies | 0 | Active |
| US11318112B2 | Pharmaceutical composition containing silybin and ve | Emerging Cross-Sectional Technologies | 0 | Active |
| US11531028B2 | Collagen type X alpha-1 assay | Physics | 0 | Active |
| US11491173B2 | Pharmaceutical composition and application thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US12343433B2 | Microencapsulation method for improving stability of anthocyanin, product therefrom and use thereof | Performing Operations; Transporting | 0 | Active |
| US12090138B2 | Pharmaceutical composition containing silybin and VE | Emerging Cross-Sectional Technologies | 0 | Active |
| US12366582B2 | Collagen type X alpha-1 assay | Physics | 0 | Active |
| US10376490B2 | Pharmaceutical composition containing silybin | Emerging Cross-Sectional Technologies | 0 | Active |
| US10307395B2 | Pharmaceutical composition containing silybin and L-carnitine | Emerging Cross-Sectional Technologies | 0 | Active |
| US10307396B2 | Pharmaceutical composition containing silybin, VE and L-carnitine | Emerging Cross-Sectional Technologies | 0 | Active |
| US10507197B2 | Pharmaceutical composition containing silibinin | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.